Share
For your role/Healthcare & life sciences

WorldbyFlow for market access and HEOR leads

In market access a price without its basis is a rumor with a decimal point. WorldbyFlow takes every price verbatim from a named source with its as-of date and a stated basis, and reads the reimbursement rules, the public budgets and the evidence beside it, so the payer story is built on figures that can be traced.

Written for Owns pricing, reimbursement, and payer strategy for a therapy.·Runs in the Health domain

Start with this one

Where this fits in your week

Owning pricing, reimbursement and payer strategy for a therapy means reconciling documents that were never meant to agree. The scans here do the reconciliation: a pricing read with basis and date, a regulatory map of negotiation and substitution rules with status honesty, the budget anatomy of the program that pays, an evidence review for the value story, and a literature review on whether the contracting model you are proposing has ever worked.

Lead scan

Pricing Read

3 credits · in-depth · about 2–4 min

Every price verbatim from a named source with its as-of date and basis. The list, net and reference picture, honestly labeled.

Try it on: a subject you already hold an opinion about, so you can grade the result against what you know.
4 more scans that fit this role

Regulatory Map

3 credits

Negotiation, substitution and coverage rules with instrument, jurisdiction and authority named, status kept honest. The perimeter of the access strategy.

Try it on Medicare drug price negotiation · Biosimilar substitution · Compounded GLP-1 drugs

Budget Anatomy

3 credits

The paying program's money tagged by status through the cycle. Where the drug spend actually sits.

Try it on Medicare Part D · Medicaid drug spending · The NHS drug budget

Evidence Review

3 credits

The evidence on the therapy read as evidence for a payer conversation: what the trials showed, what is contested, what is unknown. Never clinical guidance.

Try it on Semaglutide for weight loss · Aducanumab for Alzheimer's · Zolgensma for spinal muscular atrophy · Statins for primary prevention

Literature Review

4 credits

What the research says about value-based pricing or outcomes-based contracts, disagreements included. The reading before proposing one.

Try it on Whether value-based drug pricing lowers spending · What outcomes-based contracts deliver · How reference pricing affects access
A working path

From a first run to a result you can hand over

The order matters. The first read gives you the structure; the next ones fill the parts that are hardest to source by hand.

01

Run Pricing Read on a therapy in your portfolio

Check the basis on each figure. If list, net and reference are separated the way you separate them, the read can start the payer deck.

3 credits
02

Run Regulatory Map on the rules that shape access

Proposed kept apart from in force. The perimeter counsel can review.

3 credits
03

Run Evidence Review for the value story

What the evidence shows, for a payer reader. The honest core of the dossier.

3 credits
04

Pin the program to your Watchboard

A negotiation list, a coverage decision or a rule change becomes a watched signal.

Pinning is free; a check costs 2 credits when you ask for one.
The research bill for this path
3 + 3 + 3 = 9 credits · a Standard plan carries 20 a month
What comes back

A result whose claims carry their grades

Sourced, not asserted

Every figure and quote links to where it came from. A claim the scan could not source is marked as such rather than dressed up.

Verified or grounded
Reported or attributed
Contested
Open question

Ready to hand over

Export the reads as PDFs for the payer dossier, or share them as pages the field team can open with each price sourced.

Built to be argued with

Ask a follow-up question of any result, or run a Red Team pass that tries to break its own conclusions before someone else does. How the grades work →

See one

Research already published in this shape

Who Decides Where U.S. Hospitals Open and Close

Read the research →

Tennessee, Mississippi, North Carolina, and other states are loosening or repealing CON rules as private-equity chains and REIT landlords consolidate hospitals those regulations were designed to oversee.

Key Players · September 8, 2026 · from the Health library
Try it

Run Pricing Read on something you already know

The fastest way to judge the result is to pick a subject you know cold and read it against what you know. If a colleague sent you here with an invitation, the credits land on your account when you sign up.

Start with Pricing Read →Standard plan from $10/mo · 20 credits · all plans
Nearby roles

Other guides in healthcare & life sciences

Pharma competitive intelligence leadMedicineHospital system strategy directorHealth SystemHealthcare workforce plannerClinical WorkforceDigital health founderConcept Stress-TestPublic health analystDisease / ConditionHealth policy analyst, payer sideRegulatory MapAll 116 roles →